{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T10:41:42Z","timestamp":1773744102530,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T00:00:00Z","timestamp":1506988800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s11096-017-0534-3","type":"journal-article","created":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T07:34:06Z","timestamp":1507102446000},"page":"1185-1193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Introducing clinical pharmacy services to cardiovascular clinics at a university hospital in Northern Cyprus"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4903-1356","authenticated-orcid":false,"given":"Haider","family":"Al-Baghdadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c7i\u011fdem","family":"Koca Al-Baghdadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdikarim","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onur","family":"G\u00fcltekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arijana","family":"Me\u0161trovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rumeysa","family":"Demirdamar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bar\u00e7\u0131n","family":"\u00d6zcem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilgen","family":"Ba\u015fgut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,3]]},"reference":[{"key":"534_CR1","unstructured":"WHO. Cardiovascular diseases (CVDs). World Health Organization. http:\/\/www.who.int\/mediacentre\/factsheets\/fs317\/en\/ . Accessed 24 Dec 2016."},{"key":"534_CR2","unstructured":"WHO. NCD country profile 2014: Cyprus. World Health Organization. http:\/\/www.who.int\/nmh\/countries\/cyp_en.pdf . Accessed 05 Mar 2017."},{"issue":"5","key":"534_CR3","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1592\/phco.19.8.556.31531","volume":"19","author":"CA Bond","year":"1999","unstructured":"Bond CA, Raehl CL, Franke T. Clinical pharmacy services and hospital mortality rates. Pharmacotherapy. 1999;19(5):556\u201364.","journal-title":"Pharmacotherapy"},{"issue":"6","key":"534_CR4","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1592\/phco.28.6.816","volume":"28","author":"American College of Clinical Pharmacy","year":"2008","unstructured":"American College of Clinical Pharmacy. The definition of clinical pharmacy. Pharmacotherapy. 2008;28(6):816\u20137.","journal-title":"Pharmacotherapy"},{"issue":"3","key":"534_CR5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/j.1875-9114.1993.tb02734.x","volume":"13","author":"American College of Clinical Pharmacy","year":"1993","unstructured":"American College of Clinical Pharmacy. The strategic plan of the American College of Clinical Pharmacy, 1993. Pharmacotherapy. 1993;13(3):257\u201361.","journal-title":"Pharmacotherapy"},{"issue":"3","key":"534_CR6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s11096-014-9933-x","volume":"36","author":"SS Allemann","year":"2014","unstructured":"Allemann SS, Van Mil JW, Botermann L, Berger K, Griese N, Hersberger KE. Pharmaceutical care: the PCNE definition 2013. Int J Clin Pharm. 2014;36(3):544\u201355.","journal-title":"Int J Clin Pharm."},{"issue":"16","key":"534_CR7","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1001\/archinternmed.2011.399","volume":"171","author":"V Santschi","year":"2011","unstructured":"Santschi V, Chiolero A, Burnand B, Colosimo AL, Paradis G. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch Intern Med. 2011;171(16):1441\u201353.","journal-title":"Arch Intern Med"},{"issue":"3","key":"534_CR8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2146\/ajhp090656","volume":"68","author":"MP Morgado","year":"2011","unstructured":"Morgado MP, Morgado SR, Mendes LC, Pereira LJ, Castelo-branco M. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: review and meta-analysis. Am J Health Syst Pharm. 2011;68(3):241\u201353.","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"534_CR9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s11096-010-9474-x","volume":"33","author":"M Morgado","year":"2011","unstructured":"Morgado M, Rolo S, Castelo-branco M. Pharmacist intervention program to enhance hypertension control: a randomised controlled trial. Int J Clin Pharm. 2011;33(1):132\u201340.","journal-title":"Int J Clin Pharm"},{"issue":"18","key":"534_CR10","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1001\/archinte.1995.00430180043006","volume":"155","author":"JA Johnson","year":"1995","unstructured":"Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med. 1995;155(18):1949\u201356.","journal-title":"Arch Intern Med"},{"key":"534_CR11","unstructured":"Europe PCN. DRP-Classification V6.2. January 14, 2010. Pharmaceutical care network Europe. http:\/\/www.pcne.org\/upload\/files\/11_PCNE_classification_V6-2.pdf . Accessed 15 Dec 2016."},{"issue":"1","key":"534_CR12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/jama.1995.03530010043033","volume":"274","author":"DW Bates","year":"1995","unstructured":"Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995;274(1):29\u201334.","journal-title":"JAMA"},{"issue":"14","key":"534_CR13","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1001\/archinte.1997.00440350075007","volume":"157","author":"TS Lesar","year":"1997","unstructured":"Lesar TS, Lomaestro BM, Pohl H. Medication-prescribing errors in a teaching hospital. A 9-year experience. Arch Intern Med. 1997;157(14):1569\u201376.","journal-title":"Arch Intern Med"},{"issue":"4","key":"534_CR14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/106002809402800417","volume":"28","author":"RS Evans","year":"1994","unstructured":"Evans RS, Pestotnik SL, Classen DC, Horn SD, Bass SB, Burke JP. Preventing adverse drug events in hospitalized patients. Ann Pharmacother. 1994;28(4):523\u20137.","journal-title":"Ann Pharmacother"},{"key":"534_CR15","unstructured":"Europe PCN. Pharmaceutical care network Europe. http:\/\/www.pcne.org\/ . Accessed 15 Dec 2016."},{"issue":"4","key":"534_CR16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4103\/0975-7406.199335","volume":"8","author":"OA Abdela","year":"2016","unstructured":"Abdela OA, Bhagavathula AS, Getachew H, Kelifa Y. Risk factors for developing drug-related problems in patients with cardiovascular diseases attending Gondar University Hospital, Ethiopia. J Pharm Bioallied Sci. 2016;8(4):289\u201395.","journal-title":"J Pharm Bioallied Sci"},{"issue":"1","key":"534_CR17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1515\/afpuc-2015-0002","volume":"62","author":"B Kov\u00e1\u010dov\u00e1","year":"2015","unstructured":"Kov\u00e1\u010dov\u00e1 B, Hasilla J, \u010euri\u0161ov\u00e1 A. Medication review in inpatients at cardiology clinic\/Prehodnotenie terapie u hospitalizovan\u00fdch pacientov na kardiologickej klinike. Acta Facultatis Pharmaceuticae Universitatis Comenianae. 2015;62(1):15\u20139.","journal-title":"Acta Facultatis Pharmaceuticae Universitatis Comenianae"},{"issue":"2","key":"534_CR18","first-page":"42","volume":"3","author":"RR Abraham","year":"2014","unstructured":"Abraham RR. Drug related problems and reactive pharmacist interventions for inpatients receiving cardiovascular drugs. Int J Basic Med Sci Pharm (IJBMSP). 2014;3(2):42\u20138.","journal-title":"Int J Basic Med Sci Pharm (IJBMSP)."},{"issue":"1","key":"534_CR19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/tcrm.1.1.39.53597","volume":"1","author":"Y Koh","year":"2005","unstructured":"Koh Y, Kutty FBM, Li SC. Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender. Ther Clin Risk Manag. 2005;1(1):39\u201348.","journal-title":"Ther Clin Risk Manag"},{"key":"534_CR20","first-page":"9","volume":"11","author":"O Urbina","year":"2015","unstructured":"Urbina O, Ferr\u00e1ndez O, Luque S, Grau S, Mojal S, Pellicer R, et al. Patient risk factors for developing a drug-related problem in a cardiology ward. Ther Clin Risk Manag. 2015;11:9\u201315.","journal-title":"Ther Clin Risk Manag"},{"issue":"16","key":"534_CR21","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","volume":"128","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al. 2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):1810\u201352.","journal-title":"Circulation"},{"issue":"9582","key":"534_CR22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(07)61091-5","volume":"370","author":"A Spinewine","year":"2007","unstructured":"Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370(9582):173\u201384.","journal-title":"Lancet"},{"issue":"6","key":"534_CR23","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s11096-013-9837-1","volume":"35","author":"TR Nielsen","year":"2013","unstructured":"Nielsen TR, Andersen SE, Rasmussen M, Honor\u00e9 PH. Clinical pharmacist service in the acute ward. Int J Clin Pharm. 2013;35(6):1137\u201351.","journal-title":"Int J Clin Pharm"},{"issue":"6","key":"534_CR24","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s11096-011-9575-1","volume":"33","author":"A Bergkvist Christensen","year":"2011","unstructured":"Bergkvist Christensen A, Holmbjer L, Midl\u00f6v P, H\u00f6glund P, Larsson L, Bondesson \u00c5, et al. The process of identifying, solving and preventing drug related problems in the LIMM-study. Int J Clin Pharm. 2011;33(6):1010\u20138.","journal-title":"Int J Clin Pharm"},{"issue":"9","key":"534_CR25","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/archinternmed.2009.71","volume":"169","author":"U Gillespie","year":"2009","unstructured":"Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, Toss H, et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80\u00a0years or older: a randomized controlled trial. Arch Intern Med. 2009;169(9):894\u2013900.","journal-title":"Arch Intern Med"},{"issue":"3","key":"534_CR26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/qshc.2004.011759","volume":"14","author":"M Fertleman","year":"2005","unstructured":"Fertleman M, Barnett N, Patel T. Improving medication management for patients: the effect of a pharmacist on post-admission ward rounds. Qual Saf Health Care. 2005;14(3):207\u201311.","journal-title":"Qual Saf Health Care"},{"issue":"5","key":"534_CR27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/ijpp.12009","volume":"21","author":"SI Al-azzam","year":"2013","unstructured":"Al-azzam SI, Shara M, Alzoubi KH, Almahasneh FA, Iflaifel MH. Implementation of clinical pharmacy services at a university hospital in Jordan. Int J Pharm Pract. 2013;21(5):337\u201340.","journal-title":"Int J Pharm Pract"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-017-0534-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-017-0534-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-017-0534-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T13:39:38Z","timestamp":1719495578000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-017-0534-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,3]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["534"],"URL":"https:\/\/doi.org\/10.1007\/s11096-017-0534-3","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,3]]}}}